Smad7 restricts melanoma invasion by restoring N-cadherin expression and establishing heterotypic cell-cell

Kyle A DiVito1, Valerie A Trabosh, You-Shin Chen

  • 1Department of Biochemistry & Molecular Biology, Georgetown University School of Medicine Washington, DC, USA.

Insights

Smad7 protein prevents melanoma invasion in human skin grafts by inhibiting beta-catenin degradation and promoting N-cadherin cell adhesion. This finding offers new insights into non-canonical TGF-β signaling in cancer progression.

Area of Science:

  • Cell biology
  • Cancer research
  • Dermatology

Background:

  • Non-canonical transforming growth factor-beta (TGF-β) signaling involves diverse proteins influencing cellular processes.
  • Inhibitory-Smads, such as Smad7, play roles in regulating cell adhesion and behavior.
  • Melanoma invasion is a critical factor in cancer progression and metastasis.

Purpose of the Study:

  • To investigate the role of Smad7 in melanoma cell invasion and tumor formation in human skin grafts.
  • To elucidate the molecular mechanisms by which Smad7 affects cell adhesion and beta-catenin signaling.

Main Methods:

  • Utilized human skin graft models with fluorescently tagged melanoma cells.
  • Assessed Smad7 expression, beta-catenin phosphorylation, and N-cadherin levels.
  • Performed cell adhesion assays and immunofluorescent analysis.

Main Results:

  • Smad7-expressing melanoma cells localized near the dermal-epidermal junction and did not form tumors.
  • Control melanoma cells readily invaded the dermis and formed tumors.
  • Smad7 inhibited beta-catenin phosphorylation and increased full-length N-cadherin.
  • Smad7 promoted N-cadherin-mediated adhesion between melanoma cells and dermal fibroblasts.

Conclusions:

  • Smad7 suppresses melanoma invasion by inhibiting beta-catenin degradation and enhancing N-cadherin-mediated cell adhesion.
  • Smad7 stabilizes melanoma cell association with dermal fibroblasts, thereby mitigating invasion.
  • These findings highlight Smad7 as a potential therapeutic target for preventing melanoma metastasis.